{
  "ptid_time": "007_S_0101_2007-12-18",
  "img_path": "/data/qiuhui/data/adni/images/007_S_0101/2007-12-18/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 75,738 mm³, 96.6% above the reference mean. With a Z-score of 2.31 (99.0th percentile), this represents significant enlargement; hippocampal volume measures 6,018 mm³, 20.4% below the reference mean. With a Z-score of -1.99 (2.3th percentile), this represents moderate atrophy; whole brain volume measures 1,103,560 mm³, 2.2% above the reference mean. With a Z-score of 0.29 (61.4th percentile), this represents normal volume ; entorhinal cortex volume measures 2,811 mm³, 31.4% below the reference mean. With a Z-score of -2.13 (1.6th percentile), this represents significant atrophy; fusiform gyrus volume measures 14,661 mm³, 22.2% below the reference mean. With a Z-score of -1.89 (2.9th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 18,467 mm³, 13.5% below the reference mean. With a Z-score of -1.21 (11.3th percentile), this represents mild atrophy. ",
  "text_data": "Age is 75.6 years. Gender is Male. Education: 18 years. MMSE: 28.0. Logical Memory: 10.0. APOEε4 alleles: 2.0. Biomarker levels: Pittsburgh compound B: 2.36 SUVR (significant elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant ventricular enlargement and moderate-to-severe atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex, fusiform gyrus), despite a normal MMSE score. The presence of two APOE4 alleles further increases Alzheimer's risk. However, the preserved MMSE suggests cognitive resilience or early-stage pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely prodromal Alzheimer’s given biomarker profile).  \n\n**Confidence:** **Medium** (high confidence in neurodegeneration, but MCI diagnosis is tentative due to the discordance between structural atrophy and intact MMSE).  \n\n*Note: Follow-up with CSF biomarkers (Aβ42, p-tau) or amyloid PET would strengthen diagnostic certainty.*",
  "timestamp": "2025-07-25T21:45:36.087187"
}